Related Experiment Video
Updated: Jun 28, 2026

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
Published on: April 11, 2025
CD25 as an immune regulatory molecule expressed on myeloid dendritic cells
Julia Driesen1, Alexey Popov, Joachim L Schultze
1Laboratory for Genomics and Immunoregulation, Program Unit Molecular Immune & Cell Biology, Institute for Life and Medical Sciences Bonn (LIMES), University of Bonn, Karlrobert-Kreitenstr. 13, D-53115 Bonn, Germany.
Insights
CD25 on dendritic cells (DCs) has a new role. These DCs secrete CD25 to suppress T-cell proliferation, aiding immune suppression in diseases like cancer.
Area of Science:
- Immunology
- Cell Biology
Background:
- CD25 (alpha-chain of IL-2 receptor) on dendritic cells (DCs) was considered an activation marker.
- Mature DCs expressing CD25 and co-stimulatory molecules were thought to be fully activated.
- Human and murine DCs express CD25 but lack the IL-2 receptor beta-chain, essential for IL-2 signaling, leaving CD25's function undefined.
Purpose of the Study:
- To review recent findings on CD25 expression and secretion by human myeloid regulatory DCs.
- To explore the biological function of CD25 in DC maturation and immune regulation.
- To discuss the implications of DC-derived CD25 in human diseases, including cancer and chronic infections.
Main Methods:
- Review of recent scientific literature on CD25 expression in dendritic cells.
- Analysis of studies investigating the co-expression of CD25 and indoleamine 2,3-dioxygenase (IDO) in regulatory DCs.
- Examination of the role of secreted CD25 in T-cell function and immune suppression.
Main Results:
- Human myeloid regulatory DCs co-express CD25 and IDO, inhibiting T-cell function.
- Secreted CD25 by DCs can bind IL-2, suppressing T-cell proliferation.
- This mechanism provides an accessory pathway for DC-mediated immune suppression.
Conclusions:
- CD25 on regulatory DCs has a novel function in immune suppression beyond being a mere activation marker.
- DC-derived CD25 represents a significant mechanism for controlling T-cell responses.
- Understanding DC-derived CD25 is crucial for therapeutic strategies in cancer and chronic infections.
Abstract:
CD25 (alpha-chain of IL-2 receptor) on dendritic cells (DC) has been previously regarded as an activation marker. DC that concomitantly express surface CD25 and co-stimulatory molecules were considered to be fully mature. While both murine and human DC can express CD25, they do not express the beta-chain of the IL-2 receptor, which is indispensable for the execution of IL-2 signaling. The biological function of CD25 during the DC maturation therefore still remains undefined. In this review we focus on recent findings, describing CD25 expression and secretion by human myeloid regulatory DC. These DC co-express CD25 and the immunoregulatory enzyme indoleamine 2,3-dioxygenase (IDO) and inhibit T-cell function. CD25, expressed and secreted by such DC may capture IL-2 and thereby suppress T-cell proliferation, by this means providing an accessory mechanism of DC-mediated immune suppression. We also discuss the implication of DC-derived CD25 for human disease in both cancer and chronic infection.
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Differentiation of Common Myeloid Progenitor Cells
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

